Reversal of tumor-induced immunosuppression by TGF-β inhibitors

被引:101
作者
Wojtowicz-Praga, S
机构
关键词
TGF-beta; TGF-beta inhibitors; malignancy; cancer; immunosuppression;
D O I
10.1023/A:1022951824806
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The immune system is responsible for the early detection and destruction of newly transformed malignant cells. Some transformed cells become immunologically invisible by passive avoidance of immune surveillance (i.e., when tumor cells are immunologically indistinguishable from normal cells). Other transformed cells actively secrete cytokines that effectively blind the immune system to the presence of abnormal antigens on the tumor cell surface. Transforming growth factor-beta ("TGF-beta"), which is expressed by a majority of malignant tumors, is the most potent immunosuppressor and therefore, the most likely cytokine to be responsible for the latter phenomenon. In addition to playing a key role in tumor-induced immunosuppression, TGF-beta stimulates angiogenesis. Interestingly, tumor cells eventually become refractory to TGF-beta-mediated growth arrest, either due to loss of TGF-beta receptors or due to dysregulation in TGF-beta signaling pathways. Neutralization of TGF-beta or inhibition of its production is an effective method of cancer treatment in variety of animal models. Several agents targeting TGF-beta are in the early stages of development and include anti-TGF-beta antibodies, small molecule inhibitors of TGF-beta, Smad inhibitors and antisense gene therapy. Since tumors may express more than one isoform of TGF-beta, these new drugs should target all three TGF-beta isoforms produced by human tumors. The effects of therapies targeting TGF-beta are likely to be synergistic with cytotoxic chemotherapy and immunotherapy. Reversal of TGF-beta-induced immunosuppression is a new and promising approach to cancer therapy, with potential applications in other diseases such as AIDS.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 135 条
[1]   Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation [J].
Anscher, MS ;
Marks, LB ;
Shafman, TD ;
Clough, R ;
Huang, H ;
Tisch, A ;
Munley, M ;
Herndon, JE ;
Garst, J ;
Crawford, J ;
Jirtle, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3758-3765
[2]   The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy [J].
Anscher, MS ;
Kong, FM ;
Jirtle, RL .
LUNG CANCER, 1998, 19 (02) :109-120
[3]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[4]   TYPE-BETA TRANSFORMING GROWTH-FACTOR IN HUMAN-PLATELETS - RELEASE DURING PLATELET DEGRANULATION AND ACTION ON VASCULAR SMOOTH-MUSCLE CELLS [J].
ASSOIAN, RK ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1986, 102 (04) :1217-1223
[5]   Multiple forms of TGF-beta(1), in breast tissues: A biologically active form of the small latent complex of TGF-beta 1 [J].
Baillie, R ;
Coombes, RC ;
Smith, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) :1566-1573
[6]  
BANDYOPADHYAY A, 2002, PAACR, P436
[7]   Regulation of osteogenesis by fetuin [J].
Binkert, C ;
Demetriou, M ;
Sukhu, B ;
Szweras, M ;
Tenenbaum, HC ;
Dennis, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) :28514-28520
[8]   The recombinant proregion of transforming growth factor beta 1 (Latency-associated peptide) inhibits active transforming growth factor beta 1 in transgenic mice [J].
Bottinger, EP ;
Factor, VM ;
Tsang, MLS ;
Weatherbee, JA ;
Kopp, JB ;
Qian, SW ;
Wakefield, LM ;
Roberts, AB ;
Thorgeirsson, SS ;
Sporn, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5877-5882
[9]  
Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO
[10]  
2-M